Page 163 - Tata_Chemicals_yearly-reports-2020-2021

Integrated Report Statutory Reports Financial Statements
1-59 60-146 Standalone

Standalone Statement of Cash Flows for the year ended March 31, 2021

` in crore
Year ended Year ended
March 31, 2021 March 31, 2020
A Cash flows from operating activities
Profit before tax from continuing operations 613.97 834.32
Profit before tax from discontinued operations - 6,128.08
613.97 6,962.40
Adjustments for :
Depreciation and amortisation expense 197.32 149.50
Finance costs 18.74 43.37
Interest income (47.34) (40.99)
Dividend income (72.91) (123.22)
Gain on demerger of discontinued operation (net) (note 34) - (6,220.15)
Net gain on sale of current investments (45.82) (121.27)
Provision for employee benefits expense 30.05 28.39
Provision for doubtful debts and advances/bad debts written off (net) 0.18 9.40
Provision for contingencies (net) 7.12 (5.33)
Liabilities no longer required written back (3.25) -
Provision for exceptional item (note 34) - 92.07
Foreign exchange gain/(loss) (net) 4.15 (2.74)
Loss/(profit) on assets sold or discarded (net) 2.78 (8.34)
Operating profit before working capital changes 704.99 763.09
Adjustments for :
Trade receivables, other financial assets and other assets 58.38 (66.07)
Inventories 179.53 (73.49)
Trade payables, other financial liabilities and other liabilities (120.09) 22.11
Cash generated from operations 822.81 645.64
Taxes paid (net of refund) (151.06) (218.27)
Net cash generated from operating activities 671.75 427.37
B Cash flows from investing activities
Acquisition of property, plant and equipment (including capital work-in-progress) (546.87) (698.29)
Acquisition of intangible assets (including intangible asset under development) (3.77) (3.02)
Proceeds from sale of property, plant and equipment 0.54 11.88
Proceeds from sale of current investments 3,335.53 8,330.19
Purchase of non-current investments (198.90) -
Purchase of current investments (3,269.99) (7,354.00)
Bank balances not considered as cash and cash equivalents 169.99 (737.41)
Payment on sale of discontinued operations (net) (note 34) - (8.00)
Interest received 37.76 42.79
Dividend received
- From subsidiaries 26.33 25.93
- From joint venture 26.49 72.24
- From others 20.09 25.05
Net cash used in investing activities (402.80) (292.64)

161